Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

Lavinia Fabeni, Giulia Berno, Joseph Fokam, Ada Bertoli, Claudia Alteri, Caterina Gori, Federica Forbici, Desiré Takou, Alessandra Vergori, Mauro Zaccarelli, Gaetano Maffongelli, Vanni Borghi, Alessandra Latini, Alfredo Pennica, Claudio Maria Mastroianni, Francesco Montella, Cristina Mussini, Massimo Andreoni, Andrea Antinori, Carlo Federico PernoMaria Mercedes Santoro, Resistance Study Group, Manuela Colafigli, Antonio Cristaudo, Massimo Giuliani, Anna Pacifici

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

HIV-1 non-B subtypes/circulating recombinant forms (CRFs) are increasing worldwide. Since subtype identification can be clinically relevant, we assessed the added value in HIV-1 subtyping using updated molecular phylogeny (Mphy) and the performance of routinely used automated tools. Updated Mphy (2015 updated reference sequences), used as a gold standard, was performed to subtype 13,116 HIV-1 protease/reverse transcriptase sequences and then compared with previous Mphy (reference sequences until 2014) and with COMET, REGA, SCUEAL, and Stanford subtyping tools. Updated Mphy classified subtype B as the most prevalent (73.4%), followed by CRF02_AG (7.9%), C (4.6%), F1 (3.4%), A1 (2.2%), G (1.6%), CRF12_BF (1.2%), and other subtypes (5.7%). A 2.3% proportion of sequences were reassigned as different subtypes or CRFs because of misclassification by previous Mphy. Overall, the tool most concordant with updated Mphy was Stanford-v8.1 (95.4%), followed by COMET (93.8%), REGA-v3 (92.5%), Stanford-old (91.1%), and SCUEAL (85.9%). All the tools had a high sensitivity (≥98.0%) and specificity (≥95.7%) for subtype B. Regarding non-B subtypes, Stanford-v8.1 was the best tool for C, D, and F subtypes and for CRFs 01, 02, 06, 11, and 36 (sensitivity, ≥92.6%; specificity, ≥99.1%). A1 and G subtypes were better classified by COMET (92.3%) and REGA-v3 (98.6%), respectively. Our findings confirm Mphy as the gold standard for accurate HIV-1 subtyping, although Stanford-v8.1, occasionally combined with COMET or REGA-v3, represents an effective subtyping approach in clinical settings. Periodic updating of HIV-1 reference sequences is fundamental to improving subtype characterization in the context of an effective epidemiological surveillance of non-B strains.

Original languageEnglish
Pages (from-to)2827-2837
Number of pages11
JournalJournal of Clinical Microbiology
Volume55
Issue number9
DOIs
Publication statusPublished - Sep 2017

Fingerprint

Phylogeny
HIV-1
Sensitivity and Specificity

Keywords

  • Journal Article

Cite this

Fabeni, L., Berno, G., Fokam, J., Bertoli, A., Alteri, C., Gori, C., ... Pacifici, A. (2017). Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains. Journal of Clinical Microbiology, 55(9), 2827-2837. https://doi.org/10.1128/JCM.00656-17

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains. / Fabeni, Lavinia; Berno, Giulia; Fokam, Joseph; Bertoli, Ada; Alteri, Claudia; Gori, Caterina; Forbici, Federica; Takou, Desiré; Vergori, Alessandra; Zaccarelli, Mauro; Maffongelli, Gaetano; Borghi, Vanni; Latini, Alessandra; Pennica, Alfredo; Mastroianni, Claudio Maria; Montella, Francesco; Mussini, Cristina; Andreoni, Massimo; Antinori, Andrea; Perno, Carlo Federico; Santoro, Maria Mercedes; Resistance Study Group; Colafigli, Manuela; Cristaudo, Antonio; Giuliani, Massimo; Pacifici, Anna.

In: Journal of Clinical Microbiology, Vol. 55, No. 9, 09.2017, p. 2827-2837.

Research output: Contribution to journalArticle

Fabeni, L, Berno, G, Fokam, J, Bertoli, A, Alteri, C, Gori, C, Forbici, F, Takou, D, Vergori, A, Zaccarelli, M, Maffongelli, G, Borghi, V, Latini, A, Pennica, A, Mastroianni, CM, Montella, F, Mussini, C, Andreoni, M, Antinori, A, Perno, CF, Santoro, MM, Resistance Study Group, Colafigli, M, Cristaudo, A, Giuliani, M & Pacifici, A 2017, 'Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains', Journal of Clinical Microbiology, vol. 55, no. 9, pp. 2827-2837. https://doi.org/10.1128/JCM.00656-17
Fabeni, Lavinia ; Berno, Giulia ; Fokam, Joseph ; Bertoli, Ada ; Alteri, Claudia ; Gori, Caterina ; Forbici, Federica ; Takou, Desiré ; Vergori, Alessandra ; Zaccarelli, Mauro ; Maffongelli, Gaetano ; Borghi, Vanni ; Latini, Alessandra ; Pennica, Alfredo ; Mastroianni, Claudio Maria ; Montella, Francesco ; Mussini, Cristina ; Andreoni, Massimo ; Antinori, Andrea ; Perno, Carlo Federico ; Santoro, Maria Mercedes ; Resistance Study Group ; Colafigli, Manuela ; Cristaudo, Antonio ; Giuliani, Massimo ; Pacifici, Anna. / Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains. In: Journal of Clinical Microbiology. 2017 ; Vol. 55, No. 9. pp. 2827-2837.
@article{42094d5f51f6410f8c0eca517db18380,
title = "Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains",
abstract = "HIV-1 non-B subtypes/circulating recombinant forms (CRFs) are increasing worldwide. Since subtype identification can be clinically relevant, we assessed the added value in HIV-1 subtyping using updated molecular phylogeny (Mphy) and the performance of routinely used automated tools. Updated Mphy (2015 updated reference sequences), used as a gold standard, was performed to subtype 13,116 HIV-1 protease/reverse transcriptase sequences and then compared with previous Mphy (reference sequences until 2014) and with COMET, REGA, SCUEAL, and Stanford subtyping tools. Updated Mphy classified subtype B as the most prevalent (73.4{\%}), followed by CRF02_AG (7.9{\%}), C (4.6{\%}), F1 (3.4{\%}), A1 (2.2{\%}), G (1.6{\%}), CRF12_BF (1.2{\%}), and other subtypes (5.7{\%}). A 2.3{\%} proportion of sequences were reassigned as different subtypes or CRFs because of misclassification by previous Mphy. Overall, the tool most concordant with updated Mphy was Stanford-v8.1 (95.4{\%}), followed by COMET (93.8{\%}), REGA-v3 (92.5{\%}), Stanford-old (91.1{\%}), and SCUEAL (85.9{\%}). All the tools had a high sensitivity (≥98.0{\%}) and specificity (≥95.7{\%}) for subtype B. Regarding non-B subtypes, Stanford-v8.1 was the best tool for C, D, and F subtypes and for CRFs 01, 02, 06, 11, and 36 (sensitivity, ≥92.6{\%}; specificity, ≥99.1{\%}). A1 and G subtypes were better classified by COMET (92.3{\%}) and REGA-v3 (98.6{\%}), respectively. Our findings confirm Mphy as the gold standard for accurate HIV-1 subtyping, although Stanford-v8.1, occasionally combined with COMET or REGA-v3, represents an effective subtyping approach in clinical settings. Periodic updating of HIV-1 reference sequences is fundamental to improving subtype characterization in the context of an effective epidemiological surveillance of non-B strains.",
keywords = "Journal Article",
author = "Lavinia Fabeni and Giulia Berno and Joseph Fokam and Ada Bertoli and Claudia Alteri and Caterina Gori and Federica Forbici and Desir{\'e} Takou and Alessandra Vergori and Mauro Zaccarelli and Gaetano Maffongelli and Vanni Borghi and Alessandra Latini and Alfredo Pennica and Mastroianni, {Claudio Maria} and Francesco Montella and Cristina Mussini and Massimo Andreoni and Andrea Antinori and Perno, {Carlo Federico} and Santoro, {Maria Mercedes} and {Resistance Study Group} and Manuela Colafigli and Antonio Cristaudo and Massimo Giuliani and Anna Pacifici",
note = "Copyright {\circledC} 2017 American Society for Microbiology.",
year = "2017",
month = "9",
doi = "10.1128/JCM.00656-17",
language = "English",
volume = "55",
pages = "2827--2837",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

AU - Fabeni, Lavinia

AU - Berno, Giulia

AU - Fokam, Joseph

AU - Bertoli, Ada

AU - Alteri, Claudia

AU - Gori, Caterina

AU - Forbici, Federica

AU - Takou, Desiré

AU - Vergori, Alessandra

AU - Zaccarelli, Mauro

AU - Maffongelli, Gaetano

AU - Borghi, Vanni

AU - Latini, Alessandra

AU - Pennica, Alfredo

AU - Mastroianni, Claudio Maria

AU - Montella, Francesco

AU - Mussini, Cristina

AU - Andreoni, Massimo

AU - Antinori, Andrea

AU - Perno, Carlo Federico

AU - Santoro, Maria Mercedes

AU - Resistance Study Group

AU - Colafigli, Manuela

AU - Cristaudo, Antonio

AU - Giuliani, Massimo

AU - Pacifici, Anna

N1 - Copyright © 2017 American Society for Microbiology.

PY - 2017/9

Y1 - 2017/9

N2 - HIV-1 non-B subtypes/circulating recombinant forms (CRFs) are increasing worldwide. Since subtype identification can be clinically relevant, we assessed the added value in HIV-1 subtyping using updated molecular phylogeny (Mphy) and the performance of routinely used automated tools. Updated Mphy (2015 updated reference sequences), used as a gold standard, was performed to subtype 13,116 HIV-1 protease/reverse transcriptase sequences and then compared with previous Mphy (reference sequences until 2014) and with COMET, REGA, SCUEAL, and Stanford subtyping tools. Updated Mphy classified subtype B as the most prevalent (73.4%), followed by CRF02_AG (7.9%), C (4.6%), F1 (3.4%), A1 (2.2%), G (1.6%), CRF12_BF (1.2%), and other subtypes (5.7%). A 2.3% proportion of sequences were reassigned as different subtypes or CRFs because of misclassification by previous Mphy. Overall, the tool most concordant with updated Mphy was Stanford-v8.1 (95.4%), followed by COMET (93.8%), REGA-v3 (92.5%), Stanford-old (91.1%), and SCUEAL (85.9%). All the tools had a high sensitivity (≥98.0%) and specificity (≥95.7%) for subtype B. Regarding non-B subtypes, Stanford-v8.1 was the best tool for C, D, and F subtypes and for CRFs 01, 02, 06, 11, and 36 (sensitivity, ≥92.6%; specificity, ≥99.1%). A1 and G subtypes were better classified by COMET (92.3%) and REGA-v3 (98.6%), respectively. Our findings confirm Mphy as the gold standard for accurate HIV-1 subtyping, although Stanford-v8.1, occasionally combined with COMET or REGA-v3, represents an effective subtyping approach in clinical settings. Periodic updating of HIV-1 reference sequences is fundamental to improving subtype characterization in the context of an effective epidemiological surveillance of non-B strains.

AB - HIV-1 non-B subtypes/circulating recombinant forms (CRFs) are increasing worldwide. Since subtype identification can be clinically relevant, we assessed the added value in HIV-1 subtyping using updated molecular phylogeny (Mphy) and the performance of routinely used automated tools. Updated Mphy (2015 updated reference sequences), used as a gold standard, was performed to subtype 13,116 HIV-1 protease/reverse transcriptase sequences and then compared with previous Mphy (reference sequences until 2014) and with COMET, REGA, SCUEAL, and Stanford subtyping tools. Updated Mphy classified subtype B as the most prevalent (73.4%), followed by CRF02_AG (7.9%), C (4.6%), F1 (3.4%), A1 (2.2%), G (1.6%), CRF12_BF (1.2%), and other subtypes (5.7%). A 2.3% proportion of sequences were reassigned as different subtypes or CRFs because of misclassification by previous Mphy. Overall, the tool most concordant with updated Mphy was Stanford-v8.1 (95.4%), followed by COMET (93.8%), REGA-v3 (92.5%), Stanford-old (91.1%), and SCUEAL (85.9%). All the tools had a high sensitivity (≥98.0%) and specificity (≥95.7%) for subtype B. Regarding non-B subtypes, Stanford-v8.1 was the best tool for C, D, and F subtypes and for CRFs 01, 02, 06, 11, and 36 (sensitivity, ≥92.6%; specificity, ≥99.1%). A1 and G subtypes were better classified by COMET (92.3%) and REGA-v3 (98.6%), respectively. Our findings confirm Mphy as the gold standard for accurate HIV-1 subtyping, although Stanford-v8.1, occasionally combined with COMET or REGA-v3, represents an effective subtyping approach in clinical settings. Periodic updating of HIV-1 reference sequences is fundamental to improving subtype characterization in the context of an effective epidemiological surveillance of non-B strains.

KW - Journal Article

U2 - 10.1128/JCM.00656-17

DO - 10.1128/JCM.00656-17

M3 - Article

C2 - 28701420

VL - 55

SP - 2827

EP - 2837

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 9

ER -